NCT04790136View on ClinicalTrials.gov

Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

April 16, 2021

Study Completion Date

May 12, 2021

Conditions
Comparative Bioavailability
Interventions
DRUG

GLA-015

administration followed by PK blood sampling

DRUG

"DAC C-052 Cannabidiol / NRF 22.10 Oily cannabidiol solution 100 mg/ml"

administration followed by PK blood sampling

Trial Locations (1)

99084

SocraTec R&D GmbH Clinical Pharmacology Unit, Erfurt

Sponsors
All Listed Sponsors
collaborator

Glatt Pharmaceutical Services GmbH & Co. KG

UNKNOWN

collaborator

SocraMetrics GmbH

INDUSTRY

lead

SocraTec R&D GmbH

OTHER